Detalles de la búsqueda
1.
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.
Eur J Nucl Med Mol Imaging
; 49(5): 1650-1660, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34773163
2.
Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy-results from a prospective trial.
Eur J Nucl Med Mol Imaging
; 47(5): 1046-1055, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31811344
3.
Biological imaging for individualized therapy in radiation oncology: part II medical and clinical aspects.
Future Oncol
; 14(8): 751-769, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29521519
4.
Using a contextualized sensemaking model for interaction design: A case study of tumor contouring.
J Biomed Inform
; 65: 145-158, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27932222
5.
Analysis of relation between hypoxia PET imaging and tissue-based biomarkers during head and neck radiochemotherapy.
Acta Oncol
; 55(11): 1299-1304, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27593107
6.
FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.
Strahlenther Onkol
; 190(10): 957-61, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24928248
7.
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation.
Clin Transl Radiat Oncol
; 33: 120-127, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243023
8.
Evolution of the hypoxic compartment on sequential oxygen partial pressure maps during radiochemotherapy in advanced head and neck cancer.
Phys Imaging Radiat Oncol
; 17: 100-105, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33898787
9.
Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial.
Radiother Oncol
; 159: 75-81, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753155
10.
Lymphocyte Infiltration Determines the Hypoxia-Dependent Response to Definitive Chemoradiation in Head-and-Neck Cancer: Results from a Prospective Imaging Trial.
J Nucl Med
; 62(4): 471-478, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859699
11.
18F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy.
Cancers (Basel)
; 13(14)2021 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34298663
12.
Convolutional neural networks for head and neck tumor segmentation on 7-channel multiparametric MRI: a leave-one-out analysis.
Radiat Oncol
; 15(1): 181, 2020 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727525
13.
Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
Theranostics
; 10(20): 9395-9406, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32802199
14.
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer.
Radiother Oncol
; 150: 128-135, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32544609
15.
Automatic Tumor Segmentation With a Convolutional Neural Network in Multiparametric MRI: Influence of Distortion Correction.
Tomography
; 5(3): 292-299, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31572790
16.
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clin Cancer Res
; 13(6): 1868-74, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17363543
17.
Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.
Radiat Oncol
; 13(1): 183, 2018 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30241555
18.
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.
Radiat Oncol
; 13(1): 159, 2018 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30157883
19.
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
Int J Radiat Oncol Biol Phys
; 69(2): 541-51, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17869667
20.
Current status of angiogenesis inhibitors combined with radiation therapy.
Cancer Treat Rev
; 32(5): 348-64, 2006 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16713103